BI
OLMA icon

BVF Inc’s Olema Pharmaceuticals OLMA Stock Holding History

BVF Inc’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.3M Hold
5,295,893
– – 1.69% 18
2026
Q1 		$79M Hold
5,295,893
– – 2.52% 15
2025
Q4 		$132M Hold
5,295,893
– – 4.46% 5
2025
Q3 		$51.8M Hold
5,295,893
– – 2.1% 18
2025
Q2 		$22.6M Hold
5,295,893
– – 0.81% 22
2025
Q1 		$19.9M Sell
5,295,893
-420,000
-7% -$2.11M 0.81% 24
2024
Q4 		$33.3M Sell
5,715,893
-3,420,000
-37% -$34.2M 1.13% 22
2024
Q3 		$109M Hold
9,135,893
– – 3.19% 6
2024
Q2 		$98.9M Hold
9,135,893
– – 2.77% 9
2024
Q1 		$103M Hold
9,135,893
– – 2.84% 10
2023
Q4 		$128M Hold
9,135,893
– – 3.21% 7
2023
Q3 		$113M Buy
9,135,893
+1,524,390
+20% +$15.5M 3.04% 6
2023
Q2 		$68.7M Hold
7,611,503
– – 1.92% 16
2023
Q1 		$26.4M Hold
7,611,503
– – 0.97% 33
2022
Q4 		$18.6M Hold
7,611,503
– – 0.79% 41
2022
Q3 		$21M Hold
7,611,503
– – 0.87% 38
2022
Q2 		$31M Buy
7,611,503
+200,000
+3% +$634K 1.5% 24
2022
Q1 		$31.6M Hold
7,411,503
– – 1.26% 24
2021
Q4 		$69.4M Buy
7,411,503
+750,000
+11% +$15.5M 2.52% 13
2021
Q3 		$184M Hold
6,661,503
– – 7.16% 3
2021
Q2 		$186M Hold
6,661,503
– – 6.99% 3
2021
Q1 		$221M Hold
6,661,503
– – 8.29% 2
2020
Q4 		$320M Buy
+6,661,503
New +$312M 12.6% 1

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BVF Inc's OLMA Position: Q2 2026 in Review

BVF Inc held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 5,295,893 shares worth $66.3M. The position accounts for 1.69% of the portfolio, ranked #18.

BVF Inc first reported a position in OLMA in Q4 2020 and has held it in 23 quarters since. The position peaked at $320M in Q4 2020. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • BVF Inc held 5,295,893 shares of Olema Pharmaceuticals worth $66.3M as of Q2 2026.
  • BVF Inc left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up 1.69% of BVF Inc's portfolio in Q2 2026, its #18 holding.
  • BVF Inc first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • BVF Inc's Olema Pharmaceuticals position peaked at $320M in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.